(FY)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.86M | 29.86%-338.96K | 28.32%-460.09K | 44.92%-494.35K | 13.14%-2.51M | -485.67K | -22.89%-483.25K | -6.20%-641.89K | 9.20%-897.49K | -66.31%-2.89M |
Net income from continuing operations | ---1M | 27.66%-809.08K | 362.61%2.15M | 20.09%-956.29K | -4.68%-5.29M | ---2.16M | -10.73%-1.12M | 31.79%-818.04K | 17.61%-1.2M | -42.38%-5.06M |
Operating gains losses | ---2.97M | --0 | ---- | ---- | -68.82%6.87K | ---- | ---- | ---- | ---- | --22.04K |
Depreciation and amortization | --379.56K | -26.76%40.87K | -27.77%40.87K | -27.57%40.87K | -2.67%227.38K | --58.57K | 214.70%55.81K | 79.66%56.58K | -2.83%56.43K | -7.46%233.61K |
Finance costs and discount amortization | --30.88K | -139.85%-10.13K | -66.17%8.22K | -90.37%2.24K | 30.12%92.68K | --19.74K | -6.47%25.43K | 50.03%24.3K | 310.74%23.22K | -3.28%71.23K |
Asset impairment expenditure | --116.82K | ---- | ---- | ---- | 6,049.19%489.56K | --489.56K | ---- | ---- | ---- | ---8.23K |
Provision for loans, leases and other losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Remuneration paid in stock | --273.13K | -20.43%22.72K | 175.30%44.16K | -41.38%54.8K | -40.22%288.03K | --149.97K | -72.94%28.55K | -83.28%16.04K | -40.29%93.47K | 178.46%481.82K |
Other non cashItems | --30K | -257.64%-32.89K | 101.87%3.6K | 8.60%21.41K | -53.90%82.22K | --234.26K | -55.76%20.87K | -691.47%-192.62K | -58.02%19.72K | 50.01%178.36K |
Change in working capital | --1.29M | -33.58%335.14K | -13.39%235.45K | 222.15%342.62K | 34.33%1.6M | --714.44K | 20.34%504.6K | -36.33%271.85K | -39.14%106.35K | -0.61%1.19M |
-Change in receivables | ---5.32K | 382.49%50.06K | -176.26%-4.94K | -136.08%-44.47K | 161.39%55.51K | --85.58K | -3.91%-17.72K | -91.71%6.48K | 83.44%-18.84K | -520.97%-90.42K |
-Change in prepaid assets | --26.36K | -48.35%2.16K | 140.74%11K | -192.39%-36.43K | 1,278.93%39.07K | --22.44K | 106.68%4.19K | -859.69%-27K | 237.31%39.43K | 28.42%2.83K |
-Change in payables and accrued expense | --1.01M | -42.89%197.64K | -13.50%169.49K | 1,000.30%303.63K | 71.58%814.83K | --306.57K | 18.59%346.05K | 11.77%195.94K | -196.10%-33.73K | 283.04%474.89K |
-Change in loans | --406.25K | -37.86%93.43K | -11.39%76.96K | 24.43%132.05K | -35.07%641.09K | --297.77K | -32.95%150.35K | -63.69%86.85K | -69.83%106.13K | 13.70%987.34K |
-Change in deferred charges | ---153.43K | -137.48%-8.15K | -277.86%-17.05K | -191.02%-12.16K | 87.69%-22.84K | ---67.52K | 227.92%21.73K | 115.26%9.59K | 112.13%13.36K | -202.98%-185.6K |
-Change in other working capital | --2.15K | ---- | ---- | ---- | --69.6K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | ---1.86M | 29.86%-338.96K | 28.32%-460.09K | 44.92%-494.35K | 13.14%-2.51M | ---485.67K | -22.89%-483.25K | -6.20%-641.89K | 9.20%-897.49K | -66.31%-2.89M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 25K | 0 | 0 | 0 | 91.23%-130.94K | -125K | 0 | 99.86%-2.06K | -3.88K | -36,016.06%-1.49M |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | 88.47%-5.94K | --0 | --0 | -30.67%-2.06K | ---3.88K | -1,146.31%-51.54K |
Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net business purchase and sale | --25K | ---- | ---- | ---- | 91.33%-125K | ---- | ---- | ---- | ---- | ---1.44M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --25K | --0 | --0 | --0 | 91.23%-130.94K | ---125K | --0 | 99.86%-2.06K | ---3.88K | -36,016.06%-1.49M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1.85M | -28.19%326.68K | -36.92%401.48K | 1,801.94%539.24K | -62.12%1.58M | 516.91K | 697.69%454.92K | -45.07%636.42K | -102.94%-31.68K | 80.04%4.16M |
Net issuance payments of debt | --460.42K | -101.64%-7.48K | 63.07%241.39K | 879.33%246.92K | -135.44%-378.5K | ---949.76K | 697.69%454.92K | -88.24%148.03K | 72.77%-31.68K | 9,942.69%1.07M |
Net commonstock issuance | --1.36M | --334.16K | -67.22%160.09K | --292.32K | -36.80%1.96M | --1.47M | --0 | 588.40%488.4K | --0 | 33.21%3.09M |
Proceeds from stock option exercised by employees | --30K | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --1.85M | -28.19%326.68K | -36.92%401.48K | 1,801.94%539.24K | -62.12%1.58M | --516.91K | 697.69%454.92K | -45.07%636.42K | -102.94%-31.68K | 80.04%4.16M |
Net cash flow | ||||||||||
Beginning cash position | --44.01K | -81.76%30.29K | -48.80%88.9K | -96.02%44.01K | -16.56%1.11M | --137.77K | -68.41%166.1K | -87.73%173.62K | -16.56%1.11M | 75.60%1.33M |
Current changes in cash | --12.59K | 56.66%-12.28K | -678.84%-58.61K | 104.81%44.89K | -383.97%-1.06M | ---93.77K | 91.79%-28.33K | 99.15%-7.53K | -1,149.66%-933.06K | -138.46%-219.58K |
End cash position | --56.6K | -86.93%18.01K | -81.76%30.29K | -48.80%88.9K | -96.02%44.01K | --44.01K | -23.81%137.77K | -68.41%166.1K | -87.73%173.62K | -16.56%1.11M |
Free cash from | ---1.86M | 29.86%-338.96K | 28.55%-460.09K | 45.16%-494.35K | 14.46%-2.51M | ---485.67K | -20.19%-483.25K | -6.27%-643.95K | 8.81%-901.37K | -68.87%-2.94M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.